Q2 Results 2024 (FY25)

Cigarettes & Tobacco Products · ₹26,033 Cr

Q2 FY25 Gross Sales Value: ₹3,482 crore, up 24.5% YoY (Q2 FY24: ₹2,797 crore).

Pharmaceuticals & Biotechnology · ₹4,333 Cr

Revenue, profit, margins and what management said.

Retailing · ₹6,004 Cr

Operating Revenue for 2Q FY25 (Jul-Sep 2024): ₹2,848 million, up 9.3% YoY from ₹2,606 million in 2Q FY24.

Consumer Durables · ₹5,263 Cr

Q2FY25 Net Revenue: ₹263 crore (up from ₹234 crore in Q2FY24), a ~12.4% year-on-year increase.

Capital Markets · ₹4,780 Cr

Consolidated Revenue from Operations Q2 FY25: ₹196.29 crore, up 21% YoY.

Chemicals & Petrochemicals · ₹24,820 Cr

Standalone Net Revenue from Operations for Q2FY25: ₹1,135.21 crore, up 13.01% YoY.

Consumer Durables · ₹4,534 Cr

Q2 FY25 revenue from operations: ₹5,670.47 million, a 17.99% YoY increase.

Finance · ₹28,168 Cr

Revenue from operations for Q2 FY24-25: ₹1,629.55 crore.

Industrial Products · ₹2,857 Cr

Revenue in Q2 FY25: ₹1,730 million, down 19% YoY from ₹2,135 million in Q2 FY24 (Page 12 & 11).

Textiles & Apparels · ₹3,051 Cr

Q2 FY’25 Revenue: ₹677 crore (5.4% growth YoY from ₹643 crore in Q2 FY’24).

Telecom Services · ₹2,948 Cr

Profit After Tax rose 142% YoY to ₹36.01 crore

Power · ₹16,542 Cr

Revenue, profit, margins and what management said.

Industrial Products · ₹13,462 Cr

Consolidated Net Sales for Q2 FY2025: ₹643 crore, down 18.9% year-on-year.

Cement & Cement Products · ₹4,849 Cr

Consolidated Revenue: ₹1,538 crore, down 8.2% YoY.

Finance · ₹29,232 Cr

Revenue from Operations for Q2 FY25: ₹4,706.07 crore, up 27% YoY from ₹3,706.41 crore in Q2 FY24.

Fertilizers & Agrochemicals · ₹7,331 Cr

Q2 FY25 Revenue from operations: ₹278.3 crore, virtually flat YoY (-0.1%) compared to Q2 FY24 (₹278.5 crore).

Aerospace & Defense · ₹37,298 Cr

Revenue, profit, margins and what management said.

Industrial Manufacturing · ₹8,351 Cr

Q2 FY2025 revenue: ₹3,614.2 mn, up 3.0% YoY from ₹3,509.0 mn in Q2 FY2024 (Page 5 and 4).

Ferrous Metals · ₹7,611 Cr

Total Income: ₹285 crore (41% YoY growth).

IT Software · ₹11,244 Cr

Q2 FY25 revenue reported at $156.2 million (₹13,080 million).

Construction · ₹9,181 Cr

Q2 FY25 Standalone Operating Revenue: ₹2,298.86 crore, down 20.28% YoY from ₹2,883.64 crore in Q2 FY24.

Capital Markets · ₹10,788 Cr

Revenue for Q2 FY25: ₹7,037 million, up 32% YoY from ₹5,337 million in Q2 FY24.

Pharmaceuticals & Biotechnology · ₹14,947 Cr

Q2’FY25 total income grew 5% YoY to ₹1,774 crore

Cement & Cement Products · ₹17,471 Cr

Building Product Sales for 2QFY25: 0.86 lakh Tons vs 0.77 lakh Tons in 2QFY24 (increase).

Diversified · ₹31,182 Cr

Consolidated total income: ₹5,118 crore, up 20% from ₹4,257 crore in Q2 FY 2023-24.

Textiles & Apparels · ₹35,006 Cr

Quarterly Revenue (Q2 FY25): ₹1,480.02 crore; Q2 FY24: ₹1,510.92 crore — slight decrease year-on-year.

Electrical Equipment · ₹1.4L Cr

Revenue from Operations for Q2 FY25: ₹6,584 Crore, up from ₹5,125 Crore in Q2 FY24, showing a growth of approximately 28.5%.

Banks · ₹53,655 Cr

Q2 FY25 Net Interest Income (NII): ₹1,615 crore, up 9% YoY.

Textiles & Apparels · ₹10,437 Cr

Total income for Q2 FY25: ₹17,205 million, down 3.10% YoY.

Power · ₹2,386 Cr

Revenue for FY 2023-24 was ₹1,348.64 crore.

Retailing · ₹1.5L Cr

Q2 FY25 Standalone Revenue: ₹4,036 crore; consolidated Revenue: ₹4,157 crore

Diversified FMCG · ₹3.2L Cr

Revenue, profit, margins and what management said.

Banks · ₹55,228 Cr

Total Income for Q2-FY25 (Sep-24): ₹8,484 crore, up 21.97% YoY.

Industrial Products · ₹63,009 Cr

Revenue, profit, margins and what management said.

Power · ₹82,275 Cr

Total revenue for Q2 FY25: ₹3,459 crore, increased 2% YoY from ₹3,387 crore in Q2 FY24.

Chemicals & Petrochemicals · ₹1,590 Cr

Q2 FY25 Revenue from Operations: ₹91.3 crore

Electrical Equipment · ₹1,731 Cr

Revenue for H1 FY25: ₹10,574.12 lakh, up from ₹7,522.02 lakh in H1 FY24 (40.58% growth).

₹1,694 Cr

Revenue from Operations for Q2 FY25: ₹70.8 crore, up from ₹58.8 crore in Q2 FY24 (20.4% increase).

Finance · ₹2,045 Cr

Group Aggregate Sales Q2 FY25: ₹1,823.4 crore, down 3.9% YoY from ₹1,897.5 crore in Q2 FY24.

Capital Markets · ₹1,962 Cr

Market Capitalization as on 30th September 2024: ₹3,690 crore.

₹1,738 Cr

EBITDA: ₹36.3 crore, a 45.5% year-on-year increase.

Auto Components · ₹1,847 Cr

Capacity Utilisation: Expanded installed capacity to 53.16 lakh units post-capex; current utilisation rates up to ~95% in key facilities.

Finance · ₹34,748 Cr

Q3 2024 Income from operations: ₹811.8 crore, up 10.3% YoY.

Pharmaceuticals & Biotechnology · ₹29,281 Cr

FY24 total income was ₹2,879 crore, up 7% over FY23 (₹2,693 crore).

Industrial Products · ₹37,170 Cr

Q2 FY25 Total Income (Revenue): ₹80.8 crore.

Consumable Fuels · ₹2.4L Cr

Net Sales: ₹27,271.30 Crore (down from ₹29,978.01 Crore).

Electrical Equipment · ₹2,412 Cr

Revenue from operations for H1 FY25: ₹35,954.38 lakh, up from ₹6,405.83 lakh in H1 FY24, a 5.61 times increase.

Petroleum Products · ₹2,714 Cr

Total income for Q2 Sept 2024 is ₹701.61 crore versus ₹578.27 crore for Q2 Sept 2023.

Textiles & Apparels · ₹2,927 Cr

Q2 FY25 Revenue from Operations: ₹676 crore, up 7% YoY from ₹629 crore in Q2 FY24.

Food Products · ₹583 Cr

Q2FY25 Revenue from Operations: ₹100.34 crore, up 11.7% YoY.

Paper, Forest & Jute Products · ₹594 Cr

Revenue from Operations for Q2FY25: ₹3,401 Mn, down 9% YoY from Q2FY24 (₹3,734 Mn).

Agricultural Food & other Products · ₹723 Cr

Q2FY25: ₹324 crore (12% YoY increase from ₹289 crore in Q2FY24).

Chemicals & Petrochemicals · ₹724 Cr

Q2 FY25 Revenue from Operations: ₹52.6 crore, down from ₹75.2 crore in Q2 FY24 (approx. -30% YoY).

Realty · ₹764 Cr

Q2 FY25 Income from Mall: ₹300.7 mn, up 12% YoY over Q2 FY24.

Other Utilities · ₹735 Cr

Q2 FY25 Net Sales: ₹12.87 crore, up from ₹7.10 crore in Q2 FY24; YoY growth: 81.13%.

Other Utilities · ₹750 Cr

Revenue from Operations for H1 FY25 is ₹6,085.80 lakh, up 84.39% YoY from ₹3,300.57 lakh in H1 FY24.

Industrial Manufacturing · ₹678 Cr

Revenue, profit, margins and what management said.

Other Consumer Services · ₹869 Cr

Total Revenue for H1 FY25: ₹92.11 crore, up 16.3% YoY from ₹79.24 crore in H1 FY24.

Industrial Products · ₹829 Cr

HY1 FY 2024-25 Revenue: ₹63,697.82 lakh vs ₹60,414.77 lakh in HY1 FY 2023-24; approx. 5.4% YoY increase.

Finance · ₹897 Cr

Q2 FY25 Total Revenue: ₹23.5 crore, up 46% YoY.

Pharmaceuticals & Biotechnology · ₹768 Cr

Revenue, profit, margins and what management said.

Industrial Products · ₹1,037 Cr

Q2FY25 total revenue: ₹335.0 crore, down from ₹362.6 crore in Q2FY24 (approx. 7.6% decline YoY).

Construction · ₹800 Cr

Q2 FY25 Total Revenue from Operations: ₹9,524.7 lakh.

Food Products · ₹796 Cr

Revenue, profit, margins and what management said.

Healthcare Services · ₹1,145 Cr

Total consolidated sales/revenue for Q2 FY 2024-25: ₹3,258.35 lakh, up from ₹2,192.52 lakh in Q2 FY 2023-24 (approx. +48.5% YoY).

Pharmaceuticals & Biotechnology · ₹836 Cr

Q2 FY25 Net Revenue: ₹117.01 crore, up 11.67% YoY from ₹104.78 crore in Q2 FY24.

₹1,053 Cr

Television business revenue for Q2 FY25: ₹74.3 crore.

Non-Ferrous Metals · ₹1,112 Cr

Total Revenue for Q2FY25: ₹1,454 million, up 15% from ₹1,268 million in Q2FY24.

Industrial Products · ₹1,001 Cr

FY24 Revenue: ₹6,218 million, a 5.5% increase from FY23 revenue of ₹5,891 million.

₹1,157 Cr

Consolidated: ₹1,602 Mn (down 21.1% YoY from ₹2,031 Mn in Q2-FY24).

Chemicals & Petrochemicals · ₹1,052 Cr

Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore).

Pharmaceuticals & Biotechnology · ₹1,027 Cr

Revenue, profit, margins and what management said.

Metals & Minerals Trading · ₹1,116 Cr

Q2 FY25 Revenues from Operations: ₹237.73 crore, up 19.3% YoY from ₹199.10 crore in Q2 FY24.

Entertainment · ₹1,148 Cr

Year-on-year (YoY) revenue change: Decreased by 10% compared to Q2 FY23-24 (₹277 crore).

Media · ₹1,300 Cr

Consolidated Operating Revenues Q2FY25: ₹446.51 crore, down 3% YoY from ₹458.73 crore in Q2FY24.

Industrial Manufacturing · ₹1,273 Cr

WIL’s qualification for equipment worth approximately ₹700 crore per Bharat Small Reactor (BSR) plant.

Pharmaceuticals & Biotechnology · ₹1,326 Cr

Standalone: ₹895 Mn, a 74.5% YoY increase (from ₹513 Mn in Q2-FY24).

₹1,410 Cr

Q2 FY25 Net Sales: ₹109.92 crore, up 10.68% YoY.

₹1,724 Cr

Sugar Segment Q2FY25 revenue: ₹541 crore, down 23% YoY; Sugar sales volume domestic Q2FY25: 13.83 lakh qtls, down 16% YoY.

Consumer Durables · ₹1,337 Cr

Q2FY25 revenue from operations (Consolidated): ₹383.68 crore, down 4% YoY (₹400.93 crore in Q2FY24).

Commercial Services & Supplies · ₹1,551 Cr

Revenue, profit, margins and what management said.